Dale R Pfost - Net Worth and Insider Trading
Dale R Pfost Net Worth
The estimated net worth of Dale R Pfost is at least $4,588 dollars as of 2024-11-13. Dale R Pfost is the CEO of Chemomab Therapeutics Ltd and owns about 2,500 shares of Chemomab Therapeutics Ltd (CMMB) stock worth over $4,588. Details can be seen in Dale R Pfost's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dale R Pfost has not made any transactions after 2022-03-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Dale R Pfost
Dale R Pfost Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dale R Pfost owns 3 companies in total, including CalEthos Inc (GEDC) , OPKO Health Inc (OPK) , and Chemomab Therapeutics Ltd (CMMB) .
Click here to see the complete history of Dale R Pfost’s form 4 insider trades.
Insider Ownership Summary of Dale R Pfost
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GEDC | CalEthos Inc | 2007-04-30 | director |
| OPK | OPKO Health Inc | 2007-03-29 | President |
| CMMB | Chemomab Therapeutics Ltd | 2022-03-14 | director & Chief Executive Officer |
Dale R Pfost Latest Holdings Summary
Dale R Pfost currently owns a total of 1 stock. Dale R Pfost owns 2,500 shares of Chemomab Therapeutics Ltd (CMMB) as of March 14, 2022, with a value of $4,588.
Latest Holdings of Dale R Pfost
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CMMB | Chemomab Therapeutics Ltd | 2022-03-14 | 2,500 | 1.84 | 4,588 |
Holding Weightings of Dale R Pfost
Dale R Pfost Form 4 Trading Tracker
According to the SEC Form 4 filings, Dale R Pfost has made a total of 1 transactions in Chemomab Therapeutics Ltd (CMMB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Chemomab Therapeutics Ltd is the acquisition of 2,500 shares on March 14, 2022, which cost Dale R Pfost around $9,950.
Insider Trading History of Dale R Pfost
- 1
Dale R Pfost Trading Performance
GuruFocus tracks the stock performance after each of Dale R Pfost's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Dale R Pfost is -16.62%. GuruFocus also compares Dale R Pfost's trading performance to market benchmark return within the same time period. The performance of stocks bought by Dale R Pfost within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Dale R Pfost's insider trading performs compared to the benchmark.
Performance of Dale R Pfost
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -4.03 | | | | | |
| Relative Return to S&P 500(%) | -9.29 | | | | | |
Dale R Pfost Ownership Network
Ownership Network List of Dale R Pfost
Ownership Network Relation of Dale R Pfost
Dale R Pfost Owned Company Details
What does CalEthos Inc do?
Who are the key executives at CalEthos Inc?
Dale R Pfost is the director of CalEthos Inc. Other key executives at CalEthos Inc include 10 percent owner Sean Paul Fontenot , Chief Technology Officer Hyuncheol Peter Kim , and director & 10 percent owner & Chief Executive Officer Michael Campbell .
CalEthos Inc (GEDC) Insider Trades Summary
Over the past 18 months, Dale R Pfost made no insider transaction in CalEthos Inc (GEDC). Other recent insider transactions involving CalEthos Inc (GEDC) include a net sale of 100,000 shares made by Michael Campbell ,
In summary, during the past 3 months, insiders sold 100,000 shares of CalEthos Inc (GEDC) in total and bought 0 shares, with a net sale of 100,000 shares. During the past 18 months, 100,000 shares of CalEthos Inc (GEDC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 100,000 shares.
CalEthos Inc (GEDC)'s detailed insider trading history can be found in Insider Trading Tracker table.
CalEthos Inc Insider Transactions
Dale R Pfost Mailing Address
Above is the net worth, insider trading, and ownership report for Dale R Pfost. You might contact Dale R Pfost via mailing address: Acuity Pharmaceuticals Inc, 3701 Market Street, Philadelphia Pa 19104.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
